7 Results for "

3H-flunitrazepam

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "3H-flunitrazepam" in MCE Product Catalog:

Cat. No.: HY-106316
CAS No.: 111205-55-1
Purity:  99.80%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

CGS 20625 is a potent, selective and orally active partial agonist for the central benzodiazepine receptor. CGS 20625 inhibits [3H]-flunitrazepam binding to central benzodiazepine receptors with an IC50 of 1.3 nM. CGS 20625 enhances GABA in Xenopus laevis oocytes . CGS 20625 can be used for the research of pentylenetetrazol-induced seizures and anxiety .
loading...
    loading...
Cat. No.: HY-100924
CAS No.: 84454-35-3
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

β-CCB is a ligand for benzodiazepine receptor, which inhibits the binding of [ 3H]flunitrazepam and ethyl (3-[ 3H]carboline-3-carboxylate to benzodiazepine receptors, with Ki of 3-4 nM. β-CCB exhibits proconvulsant and anxiogenic effects .
loading...
    loading...
Cat. No.: HY-121116
CAS No.: 77779-60-3
Purity:  99.85%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

CGS 8216 is a non-benzodiazepine brain benzodiazepine receptor ligand that binds to rat forebrain membranes with high affinity and specificity. CGS 8216 also inhibits 3H-flunitrazepam (3H-FLU) binding to rat synaptosomal membranes and blocks 3H-FLU labeling of brain benzodiazepine receptors in vivo with potency equivalent to Diazepam .
loading...
    loading...
Cat. No.: HY-B1803
CAS No.: 41094-88-6
Synonyms: ICI 136753
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Tracazolate (ICI 136753) is an orally active non-benzodiazepine anxiolytic. Tracazolate significantly enhances the binding of the radioligand 3H-flunitrazepam ( 3H-FLU) to brain tissue benzodiazepine receptors. Tracazolate enhances the binding of γ-aminobutyric acid (GABA) to its receptors. Tracazolate exhibits anticonvulsant activity. Tracazolate can be used in anxiety-related research .
loading...
    loading...
Cat. No.: HY-189453
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

ETK-II-83 is an orally effective and blood-brain barrier-penetrant ligand for the benzodiazepine site of the GABAA receptor. ETK-II-83 displaces 3H-flunitrazepam from rat brain GABAA receptors and selectively binds to the α5-containing subtype. ETK-II-83 can be used for anxiety research .
loading...
    loading...
Cat. No.: HY-183471
CAS No.: 34966-41-1
Synonyms: SQ 65396
Cartazolate (SQ 65396) is a pyrazolopyridine modulator with benzodiazepine receptor agonist activity and cyclic AMP phosphodiesterase inhibitory activity. Cartazolate enhances the affinity of 3H-diazepam for brain-specific binding sites, regulates the GABA/benzodiazepine receptor complex, reversibly increases Na +-independent GABA receptor binding sites, and stimulates the binding of [ 3H]flunitrazepam to cerebellar membranes. Cartazolate restores punishment-suppressed behavior and exhibits anxiolytic properties. Cartazolate is applicable to anxiety-related research [3].
loading...
    loading...
Cat. No.: HY-189454
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

ETK-III-9 is an orally active and blood-brain barrier-penetrant GABAA receptor ligand. ETK-III-9 displaces 3H-flunitrazepam at the benzodiazepine site of GABAA receptors, with stronger interactions at α3β3γ2 and α5β3γ2 subtypes. ETK-III-9 exhibits a target IC50 value of 97.8 nM for rat α3/α5-containing GABAA receptors and 7.6 nM for rat α5β3γ2 subtypes. ETK-III-9 is used in anxiety research .
loading...
    loading...